You may have heard the name Harvey Risch. If not, you will likely hear about him in the not too distant future. Some, particularly in the mainstream media, will likely try to smear him as a crackpot, or, at the least, as someone who is commenting on an area of science that is outside his area of expertise. Don’t believe any of this propaganda you are likely to hear. Believe instead those who point out that Dr. Risch is a science and public policy hero for coming forward to point out the failings of Dr. Anthony Fauci, the NIAD that Fauci leads, and the FDA that is the umbrella agency over the whole sordid mess.
For most of the spring and summer, after President Trump mentioned that he thought hydroxychloroquine might be effective at stopping COVID-19, the mainstream media and the medical and public health establishment engaged in a wholly unprecedented smear campaign designed to demonize the drug and take it away from doctors who might try to follow the science and treat COVID patients with it.
The Thought Crime Division at social-media behemoth Facebook is hot on the case of yet another conservative offender. Educational non-profit PragerU is reporting that Facebook is threatening to “unpublish” the conservative group's entire page for “repeatedly” violating the platform's community standards.
A very large study of the potential role of hydroxychloroquine in preventing COVID-19 has restarted after a regulatory body in the UK re-approved the work. Known as the COPCOV study, it is being conducted by the MORU Tropical Health Network. MORU is an acronym for the Mahidol Oxford Tropical Medicine Research Unit, part of Mahidol University in Thailand.
The Food and Drug Administration has reversed course on its Emergency Use Authorization for hydroxychloroquine for the treatment of COVID-19. In a letter discussing the revocation of the EUA for the drug, FDA chief scientist Denise Hinton said the agency no longer found the drug likely to be effective in treating COVID-19.
A study that was published to great fanfare in the prestigious journal The Lancet has now been retracted. The retracted study, titled “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” was led by Dr. Mandeep R. Mehra, a cardiologist and medical director of the Brighman and Women’s Hospital Heart and Vascular Center in Boston.